drugset / Trial / NCT00924430

Interaction Study SLV337/Simvastatin

NCT00924430

Phase 1 Completed 16 enrolled Solvay Pharmaceuticals
RandomizedSingle-groupOpen-labelTreatment

Summary

To investigate the effect of multiple doses of SLV337 on the pharmacokinetics of simvastatin and simvastatin acid when co-administered in healthy male subjects

Timeline

Start
2009-06
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject SLV337 Unknown 1400 mg
Subject Simvastatin Small molecule 40 mg